13F-HR filed by Boxer Capital Management, LLC
Boxer Capital Management, LLC filed this 13F-HR for the quarter ended 2024-12-31, filed 2025-02-14, with 60 holding rows worth $1,174,519,254.
- Accession
- 0001213900-25-014345
- Filer
- CIK 2018299
- Filed
- 2025-02-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2024
A holdings report, 60 entries on the cover page, a total value of $1,174,519,254 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,174,519,254 with VALUE read as dollars as filed, 13F file number 028-25329. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 4,279,464 | $187,183,755 | dollars as filed | |
| SPRINGWORKS THERAPEUTICS INC | 85205L107 | COM | 3,421,541 | $123,620,276 | dollars as filed | |
| NUVALENT INC COM | 670703107 | Stock | 1,120,192 | $87,688,630 | dollars as filed | |
| MERUS N V | N5749R100 | COM | 1,900,000 | $79,895,000 | dollars as filed | |
| AVIDITY BIOSCIENCES INC COM | 05370A108 | Stock | 1,727,388 | $50,232,443 | dollars as filed | |
| APELLIS PHARMACEUTICALS INC | 03753U106 | COM | 1,426,000 | $45,503,660 | dollars as filed | |
| AXSOME THERAPEUTICS INC. COM | 05464T104 | Stock | 470,000 | $39,766,700 | dollars as filed | |
| SCHOLAR ROCK HLDG CORP | 80706P103 | COM | 750,000 | $32,415,000 | dollars as filed | |
| TANGO THERAPEUTICS INC | 87583X109 | COM | 10,380,999 | $32,077,287 | dollars as filed | |
| TYRA BIOSCIENCES INC | 90240B106 | COMMON STOCK | 2,027,678 | $28,184,724 | dollars as filed | |
| ARCUS BIOSCIENCES INC | 03969F109 | COM | 1,602,200 | $23,856,758 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 600,000 | $23,520,000 | dollars as filed | |
| LEGEND BIOTECH CORP | 52490G102 | SPONSORED ADS | 700,000 | $22,778,000 | dollars as filed | |
| REPLIMUNE GROUP INC | 76029N106 | COMMON STOCK | 1,796,341 | $21,753,690 | dollars as filed | |
| GERON CORP | 374163103 | COM | 6,000,000 | $21,240,000 | dollars as filed | |
| THIRD HARMONIC BIO INC | 88427A107 | COM | 2,000,000 | $20,580,000 | dollars as filed | |
| IMMUNOVANT INC | 45258J102 | COM | 825,000 | $20,435,250 | dollars as filed | |
| ARVINAS INC | 04335A105 | COM | 1,058,614 | $20,293,630 | dollars as filed | |
| POSEIDA THERAPEUTICS INC | 73730P108 | COM | 2,000,000 | $19,200,000 | dollars as filed | |
| ROCKET PHARMACEUTICALS INC | 77313F106 | COM | 1,466,051 | $18,428,261 | dollars as filed | |
| ANAPTYSBIO INC | 032724106 | COM | 1,300,000 | $17,212,000 | dollars as filed | |
| KYMERA THERAPEUTICS INC | 501575104 | COM | 425,000 | $17,097,750 | dollars as filed | |
| ENLIVEN THERAPEUTICS INC COM | 29337E102 | Stock | 671,358 | $15,105,555 | dollars as filed | |
| Day One Biopharmaceuticals Inc | 23954D109 | Common Stock | 1,189,943 | $15,076,578 | dollars as filed | |
| ORIC PHARMACEUTICALS INC | 68622P109 | COM | 1,732,571 | $13,981,848 | dollars as filed | |
| STRUCTURE THERAPEUTICS INC COMP | 86366E106 | EQUITY | 500,000 | $13,560,000 | dollars as filed | |
| KALVISTA PHARMACEUTICALS INC | 483497103 | COM | 1,590,000 | $13,467,300 | dollars as filed | |
| UNIQURE NV | N90064101 | SHS | 750,000 | $13,245,000 | dollars as filed | |
| CULLINAN THERAPEUTICS INC | 230031106 | COM | 907,895 | $11,058,161 | dollars as filed | |
| SPYRE THERAPEUTICS INC | 00773J202 | COM NEW | 466,680 | $10,864,310 | dollars as filed | |
| NURIX THERAPEUTICS INC | 67080M103 | COMMON STOCK | 563,067 | $10,608,182 | dollars as filed | |
| KODIAK SCIENCES INC | 50015M109 | COM | 1,000,000 | $9,950,000 | dollars as filed | |
| PROTHENA CORP PLC SHS | G72800108 | Stock | 690,000 | $9,556,500 | dollars as filed | |
| JASPER THERAPEUTICS INC | 471871202 | COM NEW | 350,000 | $7,483,000 | dollars as filed | |
| ITEOS THERAPEUTICS INC | 46565G104 | COM | 946,915 | $7,272,307 | dollars as filed | |
| CHIMERIX INC COM | 16934W106 | Stock | 2,060,000 | $7,168,800 | dollars as filed | |
| Instil Bio Inc | 45783C200 | COM NEW | 355,500 | $6,786,495 | dollars as filed | |
| AMYLYX PHARMACEUTICALS INC | 03237H101 | COM | 1,750,000 | $6,615,000 | dollars as filed | |
| IOVANCE BIOTHERAPEUTICS INC | 462260100 | COM | 750,000 | $5,550,000 | dollars as filed | |
| CLIMB BIO INC | 28658R106 | COMMON STOCK | 2,603,190 | $4,685,742 | dollars as filed | |
| SUMMIT THERAPEUTICS INC | 86627T108 | COM | 250,000 | $4,461,250 | dollars as filed | |
| TERNS PHARMACEUTICALS INC COM | 880881107 | Stock | 752,000 | $4,166,080 | dollars as filed | |
| KEROS THERAPEUTICS INC COM | 492327101 | Stock | 250,000 | $3,957,500 | dollars as filed | |
| APOGEE THERAPEUTICS INC COM | 03770N101 | Stock | 86,000 | $3,895,800 | dollars as filed | |
| OLEMA PHARMACEUTICALS INC | 68062P106 | COM | 650,000 | $3,789,500 | dollars as filed | |
| Mersana Therapeutics Inc | 59045L106 | Common Stock | 2,635,000 | $3,768,050 | dollars as filed | |
| SANA BIOTECHNOLOGY INC | 799566104 | COM | 1,545,000 | $2,518,350 | dollars as filed | |
| BICARA THERAPEUTICS INC | 055477103 | COM | 135,000 | $2,351,700 | dollars as filed | |
| RELAY THERAPEUTICS INC COM | 75943R102 | Stock | 536,132 | $2,208,864 | dollars as filed | |
| PRELUDE THERAPEUTICS INC | 74065P101 | CMN | 1,708,187 | $2,177,938 | dollars as filed | |
| ZENTALIS PHARMACEUTICALS INC | 98943L107 | COMMON STOCK | 450,000 | $1,363,500 | dollars as filed | |
| BLACK DIAMOND THERAPEUTICS I | 09203E105 | COM | 506,000 | $1,082,840 | dollars as filed | |
| ORCHESTRA BIOMED HOLDINGS IN | 68572M106 | COMMON STOCK | 238,193 | $952,772 | dollars as filed | |
| ZURA BIO LTD | G9TY5A101 | COMMON STOCK | 300,000 | $750,000 | dollars as filed | |
| Milestone Pharmaceuticals Inc | 59935V107 | COM | 309,007 | $729,257 | dollars as filed | |
| BOUNDLESS BIO INC | 10170A100 | COM | 250,000 | $725,000 | dollars as filed | |
| BIOATLA INC | 09077B104 | COM | 686,347 | $405,768 | dollars as filed | |
| DBV TECHNOLOGIES S A | 23306J309 | SPONSORED ADS | 50,000 | $154,500 | dollars as filed | |
| NUVATION BIO INC | 67080N119 | WARR | 266,666 | $61,333 | dollars as filed | |
| SURROZEN INC | 86889P117 | *W EXP 08/01/203 | 66,666 | $1,660 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001213900-25-014345 | this filing | 2025-02-14 | acceptance time not in the bulk data set |